Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerability of Acthar for the Treatment of Multiple Sclerosis Relapses (TAMS)

NCT02258217 is registered in ClinicalTrials.gov with OhioHealth as lead sponsor.

NCT NCT02258217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02258217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerability of Acthar for the Treatment of Multiple Sclerosis Relapses (TAMS)
Lead sponsor
OhioHealth
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2014
Completion date
December 31, 2016
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing remitting multiple sclerosis